{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:26:12Z","timestamp":1785252372536,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071649"],"award-info":[{"award-number":["82071649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["22A320025"],"award-info":[{"award-number":["22A320025"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.rbmo.2024.104731","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:35:06Z","timestamp":1731573306000},"page":"104731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Live birth rates in IVF patients with and without polycystic ovary syndrome according to serum anti-M\u00fcllerian hormone concentrations"],"prefix":"10.1016","volume":"50","author":[{"given":"Tongjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guidong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rbmo.2024.104731_bib0001","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.rbmo.2011.02.001","article-title":"Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"22","year":"2011","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"10.1016\/j.rbmo.2024.104731_bib0002","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1210\/clinem\/dgab232","article-title":"Clinical Practice Guidelines on the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Review and Quality Assessment Study","volume":"106","author":"Al Wattar","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rbmo.2024.104731_bib0003","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejogrb.2018.04.039","article-title":"Anti-mullerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-mullerian hormone is modest","volume":"225","author":"Alson","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.rbmo.2024.104731_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12958-023-01087-5","article-title":"AMH predicts miscarriage in non-PCOS but not in PCOS related infertility ART cycles","volume":"21","author":"Arkfeld","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"10.1016\/j.rbmo.2024.104731_bib0005","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1080\/01443615.2021.1962819","article-title":"Pregnancy outcome of freeze thaw cycles of polycystic ovary syndrome patients regarding the anti-Mullerian hormone percentile","volume":"42","author":"Arslanca","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.rbmo.2024.104731_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104535","article-title":"Hypothalamic neuroglial plasticity is regulated by anti-Mullerian hormone and disrupted in polycystic ovary syndrome","volume":"90","author":"Barbotin","year":"2023","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104731_bib0007","doi-asserted-by":"crossref","first-page":"hoad026","DOI":"10.1093\/hropen\/hoad026","article-title":"Low ovarian reserve and risk of miscarriage in pregnancies derived from assisted reproductive technology","volume":"2023","author":"Chine","year":"2023","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.rbmo.2024.104731_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12958-015-0134-9","article-title":"Role of anti-Mullerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review","volume":"13","author":"Dumont","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"10.1016\/j.rbmo.2024.104731_bib0009","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.rbmo.2024.104731_bib0010","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/rep.0.1240601","article-title":"Regulation of ovarian function: the role of anti-Mullerian hormone","volume":"124","author":"Durlinger","year":"2002","journal-title":"Reproduction"},{"issue":"6","key":"10.1016\/j.rbmo.2024.104731_bib0011","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00404-019-05359-7","article-title":"Basal anti Mullerian hormone levels and endometrial thickness at midcycle can predict the outcome after clomiphene citrate stimulation in anovulatory women with PCOS, a retrospective study","volume":"300","author":"Gaba","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.rbmo.2024.104731_bib0012","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","article-title":"Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.rbmo.2024.104731_bib0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000494890","article-title":"GnRH transactivates human AMH receptor gene via Egr1 and FOXO1 in gonadotrope cells","volume":"108","author":"Garrel","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104731_bib0014","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00404-015-3901-0","article-title":"The influence of AMH on IVF success","volume":"293","author":"Gomez","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104731_bib0015","first-page":"166","article-title":"First trimester bleeding: evaluation and management","volume":"99","author":"Hendriks","year":"2019","journal-title":"Am Fam Physician"},{"issue":"11","key":"10.1016\/j.rbmo.2024.104731_bib0016","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1210\/jc.2018-01320","article-title":"Mullerian-inhibiting substance\/anti-Mullerian Hormone as a predictor of preterm birth in polycystic ovary syndrome","volume":"103","author":"Hsu","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.rbmo.2024.104731_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2019.09.039","article-title":"High antimullerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome","volume":"113","author":"Hu","year":"2020","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.rbmo.2024.104731_bib0018","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/jhrs.jhrs_130_22","article-title":"Factors influencing the pregnancy outcome of intrauterine insemination and follow-up treatment","volume":"16","author":"Huang","year":"2023","journal-title":"J Hum Reprod Sci"},{"issue":"2","key":"10.1016\/j.rbmo.2024.104731_bib0019","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.fertnstert.2020.06.015","article-title":"Highly elevated level of antimullerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction","volume":"115","author":"Kaing","year":"2021","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.rbmo.2024.104731_bib0020","first-page":"532","article-title":"Mullerian inhibiting substance\/anti-Mullerian hormone type II receptor protein and mRNA expression in the healthy and cancerous endometria","volume":"17","author":"Kim","year":"2019","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.rbmo.2024.104731_bib0021","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12958-023-01120-7","article-title":"Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes","volume":"21","author":"Kotlyar","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"issue":"12","key":"10.1016\/j.rbmo.2024.104731_bib0022","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.rbmo.2024.104731_bib0023","article-title":"The threshold effect of factors associated with spontaneous abortion in human-assisted reproductive technology","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.rbmo.2024.104731_bib0024","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/09513590.2014.899572","article-title":"Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers","volume":"30","author":"Li","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.rbmo.2024.104731_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-022-06683-1","article-title":"Anti-mullerian hormone as a predictor for live birth among women undergoing IVF\/ICSI in different age groups: an update of systematic review and meta-analysis","author":"Li","year":"2022","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.rbmo.2024.104731_bib0026","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11596-018-1954-6","article-title":"Basal serum anti-Mullerian hormone level as a predictor of clinical outcomes in freezing-all embryo transfer program","volume":"38","author":"Li","year":"2018","journal-title":"Curr Med Sci"},{"issue":"1","key":"10.1016\/j.rbmo.2024.104731_bib0027","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12884-022-04518-0","article-title":"Association of antimullerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"10.1016\/j.rbmo.2024.104731_bib0028","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/humupd\/dmu008","article-title":"Androgens in pregnancy: roles in parturition","volume":"20","author":"Makieva","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104731_bib0029","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/humrep\/der431","article-title":"Molecular characterization of corona radiata cells from patients with diminished ovarian reserve using microarray and microfluidic-based gene expression profiling","volume":"27","author":"May-Panloup","year":"2012","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.rbmo.2024.104731_bib0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/jhrs.jhrs_112_22","article-title":"The impact of high circulating anti-Mullerian hormone on endometrial thickness and outcome of assisted reproductive technology in women with polycystic ovarian syndrome: a cohort study","volume":"15","author":"Mohamed","year":"2022","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.rbmo.2024.104731_bib0031","series-title":"Threatened Miscarriage","author":"Mouri","year":"2024"},{"issue":"10409","key":"10.1016\/j.rbmo.2024.104731_bib0032","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","article-title":"National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis","volume":"402","author":"Ohuma","year":"2023","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.rbmo.2024.104731_bib0033","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/humrep\/deab181","article-title":"Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper","volume":"36","author":"Palomba","year":"2021","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104731_bib0034","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tem.2016.11.008","article-title":"Oocyte competence in women with polycystic ovary syndrome","volume":"28","author":"Palomba","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.rbmo.2024.104731_bib0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104731_bib0036","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","article-title":"Endometrial function in women with polycystic ovary syndrome: a comprehensive review","volume":"27","author":"Palomba","year":"2021","journal-title":"Hum Reprod Update"},{"issue":"5","key":"10.1016\/j.rbmo.2024.104731_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2011.08.015","article-title":"Anti-Mullerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells","volume":"96","author":"Pellatt","year":"2011","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.rbmo.2024.104731_bib0038","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.rbmo.2024.104731_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2013.12.039","article-title":"Value of antimullerian hormone as a prognostic indicator of in vitro fertilization outcome","volume":"101","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2024.104731_bib0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2016.02.007","article-title":"The value of anti-Mullerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization","volume":"200","author":"Reijnders","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.rbmo.2024.104731_bib0041","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"10.1016\/j.rbmo.2024.104731_bib0042","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejogrb.2009.02.044","article-title":"Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour","volume":"144","author":"Shynlova","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.rbmo.2024.104731_bib0043","article-title":"Anti-M\u00fcllerian hormone and follicle-stimulating hormone are poor independent predictors of live birth after assisted reproductive technology","author":"Siegel","year":"2022","journal-title":"Reproductive Sciences"},{"issue":"11","key":"10.1016\/j.rbmo.2024.104731_bib0044","doi-asserted-by":"crossref","first-page":"E1373","DOI":"10.1152\/ajpendo.00421.2012","article-title":"Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring","volume":"303","author":"Sun","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.rbmo.2024.104731_bib0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.fertnstert.2017.10.021","article-title":"Antimullerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013","volume":"109","author":"Tal","year":"2018","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.rbmo.2024.104731_bib0046","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1479-828X.2010.01232.x","article-title":"Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy","volume":"50","author":"Tremellen","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.rbmo.2024.104731_bib0047","article-title":"Causes and effects of oocyte retrieval difficulties: a retrospective study of 10,624 cycles","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.rbmo.2024.104731_bib0048","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.fertnstert.2009.09.009","article-title":"International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009","volume":"92","author":"Zegers-Hochschild","year":"2009","journal-title":"Fertil Steril"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648324009209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648324009209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T23:10:03Z","timestamp":1751757003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648324009209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1472648324009209"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2024.104731","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live birth rates in IVF patients with and without polycystic ovary syndrome according to serum anti-M\u00fcllerian hormone concentrations","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2024.104731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104731"}}